Myriad Genetics (MYGN) Reports In-Line Q2 EPS, misses on revenue, provides guidance
Go back to Myriad Genetics (MYGN) Reports In-Line Q2 EPS, misses on revenue, provides guidance| Myriad Genetics, Inc. (NASDAQ: MYGN) | Delayed: 3.17 -0.06 (1.86%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.23 | 52 Week High | $45.34 | |||
| Open | $3.24 | 52 Week Low | $15.92 | |||
| Day High | $3.28 | P/E | 1.36 | |||
| Day Low | $3.15 | EPS | $2.33 | |||
| Volume | 1,619,851 | |||||
